Drug response prediction by inferring pathway-response associations with Kernelized Bayesian Matrix Factorization
Preprint
Abstract
A key goal of computational personalized medicine is to systematically utilize genomic and other molecular features of samples to predict drug responses for a previously unseen sample. Such predictions are valuable for developing hypotheses for selecting therapies tailored for individual patients. This is especially valuable in oncology, where molecular and genetic heterogeneity of the cells has a major impact on the response. However, the prediction task is extremely challenging, raising the need for methods that can effectively model and predict drug responses. In this study, we propose a novel formulation of multi-task matrix factorization that allows selective data integration for predicting drug responses. To solve the modeling task, we extend the state-of-the-art kernelized Bayesian matrix factorization (KBMF) method with component-wise multiple kernel learning. In addition, our approach exploits the known pathway information in a novel and biologically meaningful fashion to learn the drug response associations. Our method quantitatively outperforms the state of the art on predicting drug responses in two publicly available cancer data sets as well as on a synthetic data set. In addition, we validated our model predictions with lab experiments using an in-house cancer cell line panel. We finally show the practical applicability of the proposed method by utilizing prior knowledge to infer pathway-drug response associations, opening up the opportunity for elucidating drug action mechanisms. We demonstrate that pathway-response associations can be learned by the proposed model for the well known EGFR and MEK inhibitors.Keywords
All Related Versions
This publication has 26 references indexed in Scilit:
- Integrative and Personalized QSAR Analysis in Cancer by Kernelized Bayesian Matrix FactorizationJournal of Chemical Information and Modeling, 2014
- Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapiesScientific Reports, 2014
- A community effort to assess and improve drug sensitivity prediction algorithmsNature Biotechnology, 2014
- An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small MoleculesCell, 2013
- Dependence of QSAR Models on the Selection of Trial Descriptor Sets: A Demonstration Using Nanotoxicity Endpoints of Decorated NanotubesJournal of Chemical Information and Modeling, 2013
- Drug Side-Effect Prediction Based on the Integration of Chemical and Biological SpacesJournal of Chemical Information and Modeling, 2012
- Pharmacogenomics Knowledge for Personalized MedicineClinical Pharmacology & Therapeutics, 2012
- Systematic identification of genomic markers of drug sensitivity in cancer cellsNature, 2012
- Kernel methods for predicting protein-protein interactionsBioinformatics, 2005
- A Comparison of Methods for Modeling Quantitative Structure−Activity RelationshipsJournal of Medicinal Chemistry, 2004